Skip navigation links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
International Conference on Emerging Infectious Diseases
National Center for Infectious Diseases


ICEID 2002

 Webcast

Sunday

Monday

Tuesday

   Wednesday
   Plenary Sessions
   Invited Panels
   Slide Sessions
   Meet the Experts and First Encounters
   A-Z Listing by Speakers
   A-Z Listing by Presentation Title
   A-Z Listing by Major Topic
   A-Z Listing by Agent or Disease
 Continuing Education Credits
 Program
 Organizing Committee
 Partners

ICEID 2000

International Conference on Emerging Infectious Diseases
ICEID Home Contact Us

ICEID 2002 Webcast
Presentations by Agents/Diseases

Note:
ICEID sessions that are not agent or disease-specific can be found on our other listings.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Presentations by Agents/Diseases
A-F

Acute Febrile Illness

Surveillance for Patients with Acute Febrile Illness in Egypt
Salma Afifi, U.S. Naval Medical Research Unit No. 3, Cairo, Egypt

Acute Respiratory Virus

Acute Respiratory Virus Surveillance in Cairo and Alexandria, Egypt, July 2000-June 2001
Diaa Salman, U.S. Naval Medical Research Unit No 3., Cairo, Egypt

Anaerobic Bacteria

Intestinal Anaerobic Bacteria in Early Rheumatoid Arthritis
Paavo Toivanen, Turku University, Turku, Finland
Anthrax

Anthrax in the U.S. Postal System
Michele Pearson, CDC, Atlanta, GA

An Anthrax Outbreak Averted: Public Health Response to a Contaminated Envelope on Capitol Hill, Washington, DC, 2001
V.P. Hsu, CDC, Atlanta, GA

Anthrax Vaccines
Arthur Friedlander, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD

Cutaneous Anthrax in New York City
Marcelle Layton, New York Department of Health, New York, NY

Importance of Bacillus anthracis Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated Anthrax Outbreak in the United States
A. Hoffmaster, CDC, Atlanta, GA

Inhalational Anthrax—New York City, October-November 2001
T.H. Holtz, New York City Department of Health, New York, NY

Inhalation Anthrax in Florida
Steve Wiersma, Florida Department of Health, Tallahassee, FL

Inhalation Anthrax of Unknown Source
James Hadler, Connecticut Department of Public Health, Hartford, CT

Laboratory Response in the Commonwealth of Virginia to the Intentional Release of Bacillus anthracis
Denise Pettit, Division of Consolidated Laboratory Services, Richmond, VA

Letters from Trenton: The Anthrax Investigation at the Source, New Jersey, 2001
J. Reefhuis, CDC, Atlanta, GA

Monitoring of Human Exposure to Bacillus thuringiensis After Aerial Applications for Insect Control
David Levin, University of Victoria, Victoria, BC, Canada

Public Health Laboratory Response to an Anthrax Incident in Connecticut
Donald Mayo, Connecticut State Health Department, Hartford, CT

Rapid Adaptation of a Serologic Assay for the Bioterrorism-Related Anthrax Outbreak—October-December, 2001
C.M. Greene, CDC, Atlanta, GA

Rapid Molecular Identification of B. anthracis in New York State in Response to Recent Bioterrorism Incidents
Kimberlee Musser, New York, State Department of Health, Albany, NY

Astrovirus
Incidence and Type Distribution of Astrovirus Among Spanish Children
Alicia Sánchez-Fauquier, Centro Nacional de Microbiología, Madrid, Spain
Bacillus thuringiensis
Monitoring of Human Exposure to Bacillus thuringiensis After Aerial Applications for Insect Control
David Levin, University of Victoria, Victoria, BC, Canada
Botulism
An Evaluation of an Educational Videotape to Prevent Botulism among Alaska Natives
Catherine Dentinger, CDC, Anchorage, AK
Bovine Spongiform Encephalopathy (BSE) and Creutzfeldt-Jakob Disease (CJD)

The Agent: Prions as Emerging Infectious Particles
David Bolton, New York State Institute for Basic Research, Staten Island, NY

Impact of the BSE/vCJD Outbreak: U.S. Concerns for TSEs
Ermias Belay, CDC, Atlanta, GA

The Reservoir: Bovine Spongiform Encephalopathy and What's Been Done About It
Dagmar Heim, Swiss Federal Veterinary Office, Bern-Liebefeld, Switzerland

The Unfolding Variant (vCJD) Epidemic
Robert Will, Western General Hospital, Edinburgh, United Kingdom

Calicivirus

Challenges in the Interpretation of Classical and Molecular Epidemiology Results; Two Calicivirus Outbreaks Due to Oysters, Denmark at New Year 2000
Francois-Xavier Hanon, Statens Serum Institut, Copenhagen, Denmark

Coordinating Environmental Public Health Practice with Epidemiology and Laboratory Analysis: A Waterborne Outbreak of "Norwalk-like Virus" in the Big Horn Mountains of Wyoming
Scott Seys, Wyoming Department of Health, Cheyenne, WY

Transmission of the Main Viral Pathogens Causing Gastroenteritis, NLV, SLV, and Rotavirus
Yvonne van Duynhoven,
National Institute of Public Health and the Environment, Bilthoven, The Netherlands

Campylobacter

The Acquisition of Ciprofloxacin Resistance in Travel-Associated and Home-Acquired Campylobacter jejuni Infection: A Case-Case Comparison
Iain Gillespie, Public Health Laboratory Service, London, United Kingdom

Campylobacter coli—What’s the Big Deal?
Sarah O'Brien, Public Health Laboratory Service, London, United Kingdom

Prevalence and Consequences of Fluoroquinolone-Resistant Campylobacter Infections: NARMS 1997-2000
Jennifer McClellan, CDC, Atlanta, GA

Prevalence of Salmonella spp. and Campylobacter spp. Following the Discontinued Use of Antimicrobial Growth Promoters in Broilers and Swine in Denmark
Mary Evans, Danish Veterinary Institute, Copenhagen, Denmark

Chagas Disease

Ecological Niche Modeling and Differentiation of Populations of Triatoma Brasiliensis Neiva, 1911, the Most Important Chagas Disease Vector in Northeastern Brazil (Hemiptera, Reduviidae, Triatominae)
Jane Costa, CDC, Atlanta, GA

Eradication of Chagas Disease
Gabriel Schmunis, Pan American Health Organization, Washington, DC

A Greenhouse Study to Model Potential Field Use of Genetically Modified Bacterial Symbionts for Chagas' Disease Control
Pritha Sen, CDC, Atlanta, GA

C. pneumoniae
Failure to Detect C. pneumoniae in Atherosclerotic Specimens
Silvio Pitlik, Rabin Medical Center, Petah Tikvah, Israel
Cryptococcus

Outbreak of Cryptococcus neoformans var. gattii in a Restricted Zone in British Columbia
Mike Starr, University of British Columbia Centre for Disease Control, Vancouver, BC, Canada

Cryptosporidiosis

Is Drinking Water a Risk Factor for Endemic Cryptosporidiosis in the Immunocompetent General Population of the San Francisco Bay Area?
Asheena Khalakdina, University of California at Berkeley, Berkeley, CA

Cysticercosis
Eradication of T. solium Cysticercosis
Peter Schantz, CDC, Atlanta, GA
Dengue

Bringing Dengue Prevention Down to Earth: Evaluation of a Head Start Project in Puerto Rico
Carmen Pérez-Guerra, CDC, San Juan, PR

Dengue Fever Outbreak in Hawaii—2001
Paul Effler, State of Hawaii Department of Health, Honolulu, HI

Re-introduction of Dengue 3 in Aragua, Venezuela: Clinical, Epidemiological and Laboratory Features of a New Outbreak
Guillermo Comach, Lardidev-Biomed, Universidad de Carabobo, Maracay, Venezuela

Encephalitis

Clusters of Clinical Syndromes in Patients with Unexplained Encephalitis
Carol Glaser, California Department of Health Services, Berkeley, CA

Mapping of West Nile Virus Risk in the Northeast United States Using Multi-Temporal Meteorological Satellite Data
P. Bryon Backenson, New York State Department of Health, Albany, NY

Microheterogenicity of the Volgograd Clone of West Nile Virus
Alexander Platonov, Central Research Institute of Epidemiology, Moscow, Russian Federation

Rapid Screening and Identification of West Nile Virus in Captive and Wild Birds Using Non-Invasive Environmental Samples and a Portable TaqMan RT-PCR
Johnny Callahan, Tetracore, Inc., Gaithersburg, MD

West Nile Virus First Transmission Season in Florida, 2001—More Than 400 Horse Cases and 170 Chicken Seroconversions but Only Sporadic Human Disease
Carina Blackmore, Florida Department of Health, Jacksonville, FL

West Nile Virus Infection
Deborah Asnis, Brooklyn, NY

West Nile Virus in New York City
Wilfredo Lopez, New York City Department of Health, New York, NY

Enterococcus
Quinupristin/Dalfopristin-Resistant Enterococcus faecium Isolated from Human Stools, Retail Chicken, and Retail Pork: EIP Enterococci Project
Kathryn Gay, CDC, Atlanta, GA
Enterovirus

Changes in Circulating Enterovirus Serotypes in the United States, 2001
Andy Mullins, CDC, Atlanta, GA

Detection and Typing of Enterovirus in Cerebrospinal Fluid
Blair Rosen, New York State Department of Health, Slingerlands, NY

Escherichia coli O157

Epidemiology of Shiga Toxin-Producing Escherichia coli (STEC) Infections in Connecticut, February 1, 2000-January 31, 2001
Q. Phan, Connecticut Department of Public Health, Hartford, CT

High Prevalence of Antibiotic Resistance in Enterotoxigenic E. coli (ETEC); Minnesota 2000-2001
John Besser, Minnesota Department of Health, Minneapolis, MN

Microbiologic Testing to Identify Shiga Toxin-Producing E. coli in HUS Patients: FoodNet 1997-2001
C.R. Braden, CDC, Atlanta, GA

PulseNet Experience: Software Changes and Improvements to Online E. coli National Database
Susan Hunter, CDC, Atlanta, GA

Real-time Fluorescence PCR Assays for the Detection and Characterization of Heat-Labile and Heat-Stable Enterotoxin Genes from Enterotoxigenic Escherichia coli
Nancy Strockbine, CDC, Atlanta, GA

Risk Factors for Sporadic Escherichia coli O157 Infections in the United States: A Case-Control Study in FoodNet Sites, 1999-2000
M.H. Kennedy, CDC, Atlanta, GA

Three Outbreaks of E. coli O157 Infections Due to Retail Ground Beef in Minnesota, 2000: Detection, Investigation, and Characteristics
Ellen Swanson, Minnesota Department of Health, Minneapolis, MN

Foot and Mouth Disease
Foot and Mouth Disease
Christopher Bostock, Institute of Animal Health, Compton, United Kingdom

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Top of Page

  Top of Page

 

ICEID Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed May 3, 2002

International Conference on Emerging Infectious Diseases
National Center for Infectious Diseases
Centers for Disease Control and Prevention

Privacy Policy | Accessibility
 

 U.S. Department of Health and Human Services (HHS)